Internal Medicine · Brooklyn, NY
NPI
1912323874
Since 2014
Specialty
Internal Medicine
Code 207R00000X
Group practices
3
Medicare group memberships
Hospitals
0
Hospital affiliations
374 Stockholm St
Brooklyn, NY, 11237
Phone (718) 963-7272
Groups this clinician bills Medicare through
Medicare paid, 2024
$15K
288 services
Medicare patients, 2024
94
Average age 72
Drug cost, 2024
$562K
3,782 prescriptions
Company payments, 2024
$153
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Gobinda Paul was code 99213 (office e&m - established), 82 times for 54 patients. In total Gobinda Paul billed 288 services in 17 codes, and Medicare paid $15K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-12-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Facility | 82 | 54 | $44.28 | $3,631 |
| 99213 Office E&M - Established | Office | 76 | 20 | $60.37 | $4,588 |
| 36415 Venipuncture Blood Collection | Office | 26 | 13 | $8.65 | $225 |
| 99214 Office E&M - Established | Facility | 26 | 24 | $77.34 | $2,011 |
By year: 2022 $17K for 313 services; 2023 $18K for 358 services; 2024 $15K for 288 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 26 | 13 | $8.65 | $225 |
Medicare prescription drug claims, 2024
In 2024, the drug Gobinda Paul prescribed most often to Medicare patients was Atorvastatin Calcium, with 356 prescriptions and refills. In total Gobinda Paul wrote 3,782 Medicare prescriptions that cost $562K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 356 | 826 | 142 | $3,218 |
| Amlodipine Besylate Generic | 234 | 522 | 84 | $1,051 |
| Losartan Potassium Generic | 178 | 431 | 64 | $1,346 |
| Famotidine Generic | 153 | 215 | 43 | $1,114 |
| Jardiance Empagliflozin | 143 | 216 | 43 | $121K |
| Metformin Hcl Generic | 122 | 306 | 54 | $6,527 |
| Metoprolol Succinate Generic | 114 | 272 | 49 | $1,471 |
| Pantoprazole Sodium Generic | 103 | 156 | 40 | $628 |
| Levothyroxine Sodium Generic | 85 | 188 | 33 | $1,143 |
| Tamsulosin Hcl Generic | 81 | 166 | 33 | $767 |
| Diclofenac Sodium Generic | 73 | 82 | 42 | $9,154 |
| Gabapentin Generic | 70 | 111 | 26 | $370 |
| Hydralazine Hcl Generic | 61 | 89 | 20 | $657 |
| Omeprazole Generic | 60 | 111 | 23 | $445 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 54 | 75 | 22 | $1,624 |
Brand drugs: 739 claims; generic drugs: 2,976 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Gobinda Paul $153 ($153 in general payments such as food, travel and fees) from 5 companies. The largest payer was Abbvie Inc. with $51.24.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.